BSA Pharmaceuticals SRL
BSA Pharmaceuticals reported total assets of 117,380 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Sep 2026).
The score of BSA Pharmaceuticals shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -97 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
BSA Pharmaceuticals's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 216,428 € | ||||
| Equity | −179,511 € | ||||
| Cash | 10,334 € | ||||
| EBITDA | 241,038 € | ||||
| Total assets | 117,380 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 30 Aug 2025
- Year ended 31 Dec 2023filed on 29 Oct 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 29 Aug 2022
BSA Pharmaceuticals's financial analysis
- Solvency-152.9%sector median: 22.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of BSA Pharmaceuticals
BSA Pharmaceuticals's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0759.755.270
- VAT number
- BE0759755270
- Peppol
- Registered · 0208:0759755270 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 Dec 2020
- Registered office
- 1050 Brussels
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Activities of agents involved in the wholesale of other particular products (NACE 46180)
BSA Pharmaceuticals (SRL) has been based in Brussels since 2020, active in: activities of agents involved in the wholesale of other particular products. For 2025, it reports a net profit of 216,428 € and equity of −179,511 €; its revenue is not published. Its solvency stands at -152.9%, below the median of its sector (22.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to BSA Pharmaceuticals
Companies in the same business, of comparable size and area, outside its group.
- Ajwad Activities of agents involved in the wholesale of other particular products Brussels · balance sheet 135,734 €
- Le Vinh Pharma Activities of agents involved in non-specialised wholesale Wavre · balance sheet 24,139 €
- Belderm Wholesale of pharmaceutical and medical goods Woluwe-Saint-Lambert · balance sheet 7,299 €
- Sanofi Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €218.9m
- Cardiomedic Belgium Activities of agents involved in the wholesale of other particular products Perwez · balance sheet 934,939 €
- W.P. Med Activities of agents involved in the wholesale of other particular products Aywaille · balance sheet 403,029 €
- NH Zorg Activities of agents involved in the wholesale of other particular products Aalst · balance sheet 110,515 €
- Medoxys Activities of agents involved in the wholesale of other particular products Villers-la-Ville · balance sheet 556,493 €
Frequently asked questions about BSA Pharmaceuticals
What is the revenue of BSA Pharmaceuticals?
BSA Pharmaceuticals files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of BSA Pharmaceuticals?
In Belgium, the VAT number is the company number prefixed with BE: BE0759755270 for BSA Pharmaceuticals, if the company is VAT-registered. Its company number (CBE) is 0759.755.270.
Where is the registered office of BSA Pharmaceuticals?
According to the CBE register, the registered office of BSA Pharmaceuticals is in 1050 Brussels.
What is the equity of BSA Pharmaceuticals?
At the close of the 2025 financial year, the equity of BSA Pharmaceuticals amounts to -179,511 €, a solvency of -152.9% of total assets.
Who manages BSA Pharmaceuticals?
The register lists 1 active mandates at BSA Pharmaceuticals. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of BSA Pharmaceuticals
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →